pubmed-article:12594855 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0017355 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0017262 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0664943 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0920880 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0205164 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C2911684 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0686907 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0214697 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0070351 | lld:lifeskim |
pubmed-article:12594855 | lifeskim:mentions | umls-concept:C0185117 | lld:lifeskim |
pubmed-article:12594855 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:12594855 | pubmed:dateCreated | 2003-2-20 | lld:pubmed |
pubmed-article:12594855 | pubmed:abstractText | Tapasin is a member of the MHC class I loading complex where it bridges the TAP peptide transporter to class I molecules. The main role of tapasin is assumed to be the facilitation of peptide loading and optimization of the peptide cargo. Here, we describe another important function for tapasin. In tapasin-deficient (Tpn(-/-)) mice the absence of tapasin was found to have a dramatic effect on the stability of the TAP1/TAP2 heterodimeric peptide transporter. Steady-state expression of TAP protein was reduced more than 100-fold from about 3 x 10(4) TAP molecules per wild-type splenocyte to about 1 x 10(2) TAP per Tpn(-/-) splenocyte. Thus, a major function of murine tapasin appears to be the stabilization of TAP. The low amount of TAP moleculesin Tpn(-/-) lymphocytes is likely to contribute to the severe impairment of MHC class I expression. Surprisingly, activation of Tpn(-/-) lymphocytes yielded strongly enhanced class I expression comparable to wild-type levels, although TAP expression remained low and in the magnitude of several hundred molecules per cell. The high level of class I on activated Tpn(-/-) cells depended on peptides generated by the proteasome as indicated by blockade with the proteasome-specific inhibitor lactacystin. Lymphocyte activation induced an increase in ubiquitinated proteins that are cleaved into peptides by the proteasome. These findings suggest that in the presence of a large peptide pool in the cytosol, a small number of TAP transporters is sufficient to translocate enough peptides for high class I expression. However, these class I molecules were less stable than those of wild-type cells, indicating that tapasin is not only required for stabilization of TAP but also for optimization of the spectrum of bound peptides. | lld:pubmed |
pubmed-article:12594855 | pubmed:language | eng | lld:pubmed |
pubmed-article:12594855 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12594855 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12594855 | pubmed:month | Jan | lld:pubmed |
pubmed-article:12594855 | pubmed:issn | 0014-2980 | lld:pubmed |
pubmed-article:12594855 | pubmed:author | pubmed-author:GarbiNatalioN | lld:pubmed |
pubmed-article:12594855 | pubmed:author | pubmed-author:MomburgFrankF | lld:pubmed |
pubmed-article:12594855 | pubmed:author | pubmed-author:HämmerlingGün... | lld:pubmed |
pubmed-article:12594855 | pubmed:author | pubmed-author:TiwariNeerajN | lld:pubmed |
pubmed-article:12594855 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12594855 | pubmed:volume | 33 | lld:pubmed |
pubmed-article:12594855 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12594855 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12594855 | pubmed:pagination | 264-73 | lld:pubmed |
pubmed-article:12594855 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:meshHeading | pubmed-meshheading:12594855... | lld:pubmed |
pubmed-article:12594855 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12594855 | pubmed:articleTitle | A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression. | lld:pubmed |
pubmed-article:12594855 | pubmed:affiliation | Deutsches Krebsforschungszentrum Heidelberg, Abteilung Molekulare Immunologie, Heidelberg, Germany. | lld:pubmed |
pubmed-article:12594855 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12594855 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:6890 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
entrez-gene:6891 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
entrez-gene:6892 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
entrez-gene:21354 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
entrez-gene:21355 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
entrez-gene:21356 | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12594855 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12594855 | lld:pubmed |